The Innovative Medicines Initiative (IMI) workshop, entitled Applying open innovation to bring personalised medicine to new disease areas, will take place within the framework of  EAPM conference in Dublin, on 20th and 21st of March 2013. EFA President, Breda Flood, will speak at the IMI workshop and she will present headline results of U-BIOPRED project thus far and how they could impact patients. Breda Flood will discuss why a public-private partnership is needed for severe asthma and how U-BIOPRED is tackling the challenges involved in developing personalized medicines in this area. In addition, she will provide her opinion on the keys to the project’s success thus far and identify ways in which other scientists researching personalized medicines in other disease areas can learn from the example of the U-BIOPRED project. Find out more about the IMI workshop here.

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team